Clinical Trial Update: A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase 1b open-label dose-finding study assessing the safety of combining tivozanib with temsirolimus in metastatic renal cell carcinoma; the trial status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Temsirolimus (temsirolimus)
• Tivozanib (tivozanib)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Renal Cell Carcinoma | Phase 1 | Status: COMPLETED